ASSOCIATIONS OF TUMOR-ASSOCIATED MACROPHAGE INFILTRATION WITH CYTOKINE EXTRACELLULAR MATRIX SIGNATURES IN BREAST CANCER MICROENVIRONMENT
DOI:
https://doi.org/10.15407/exp-oncology.2025.04.433Keywords:
breast cancer, tumor-associated macrophages, CD68, CD163, cytokines, immunosuppressionAbstract
Background: Tumor-associated macrophages (TAMs) are among the main regulators of the immune microenvironment of breast cancer (BC). Still, their relationships with cytokine signals and the state of the extracellular matrix (ECM) remain poorly characterized. The study aimed to evaluate associations of the degree of infiltration with CD68+ and CD163+ macrophages (Mj) with the status of pro-inflammatory and immunosuppressive cytokines, as well as with the expression of the key ECM proteins in BC tissue. Materials and Methods. Postoperative material from 67 patients with stage I—II BC was studied. TAMs infiltration and the expression of SPP1, COX-2, SERPINE2, COL1A1, and COL3A1 were assessed immunohistochemically. The serum IL-6 and IL-10 levels were determined by the ELISA. IL6, IL10, and TNF mRNA expressions were assessed by qRTPCR. Results. The high levels of IL-6 in the serum of patients (p = 0.0159) and IL10 mRNA in BC tissue (p = 0.0316) were associated with an increase in the number of CD68+ TAMs. The pronounced infiltration of CD163+ TAMs correlated with an increase in the systemic level of IL-10 (p = 0.0357), IL-6 (p = 0.0286), and local TNF expression (p = 0.001). The increased SPP1 expression was accompanied by an increase in CD163+ TAMs (p = 0.008) against the background of a decrease in the CD68+ Mj population in BC tissue (p = 0.0271). The high levels of COX-2 were also directly correlated with the degree of M2-like Mj infiltration (p = 0.0357). At the same time, COL1A1 expression was associated with increased infiltration of both TAM phenotypes, while high COL3A1 expression was associated with a decrease in CD68+ Mj in tumor tissue. The bioinformatic analysis confirmed the obtained results and also allowed us to highlight the features of the tumor microenvironment composition, which depended on the degree of TAM infiltration in BC tissue of different molecular subtypes. Conclusions. The results demonstrated the existence of a single regulatory axis, “TAMs — cytokines — ECM”, which determined the development of the immunosuppressive and invasive BC microenvironment. The predominance of CD163+ Mj against the background of increased levels of IL-10, SPP1, and COX-2 was associated with a high degree of BC malignancy.
References
Moura T, Laranjeira P, Caramelo O, et al. Breast cancer and tumor microenvironment: the crucial role of immune cells. Curr Oncol. 2025;32(3):143. https://doi.org/10.3390/curroncol32030143
Guo L, Kong D, Liu J, et al. Breast cancer heterogeneity and its implication in personalized precision therapy. Exp Hematol Oncol. 2023;12(1):3. https://doi.org/10.1186/s40164-022-00363-1.
Chekhun V, Martynyuk O, Lukianova Y, et al. Features of breast cancer in patients of young age: search for diagnosis optimization and personalized treatment. Exp Oncol. 2023;45(2):139-150. https://doi.org/10.15407/exp-oncolo- gy.2023.02.139
Allison E, Edirimanne S, Matthews J, et al. Breast cancer survival outcomes and tumor-associated macrophage markers: a systematic review and meta-analysis. Oncol Th r. 2023;11(1):27-48. https://doi.org/10.1007/s40487-022-00214-3
Pavlova A, Mushii O, Bazas V, et al. Tumor-associated macrophages: relationship with clinical status of patients and molecular biological features of breast cancer. Exp Oncol. 2025;47(2):197-206. https://doi.org/10.15407/exp- oncology.2025.02.197
Manore SG, Doheny DL, Wong GL, et al. IL-6/JAK/STAT3 signaling in breast cancer metastasis: biology and treatment. Front Oncol. 2022;12:866014. https://doi.org/10.3389/fonc.2022.866014
Felcher CM, Bogni ES, Kordon EC. IL-6 cytokine family: a putative target for breast cancer prevention and treat- ment. Int J Mol Sci. 2022;23(3):1809. https://doi.org/10.3390/ijms23031809
Jin H, Meng X, Feng J. Mechanisms of tumor-associated macrophages in breast cancer and treatment strategy. Front Immunol. 2025;16:1560393. https://doi.org/10.3389/fimmu.2025.1560393
Wolczyk D, Zaremba-Czogalla M, Hryniewicz-Jankowska A, et al. TNF-promotes breast cancer cell migration and enhances the concentration of membrane-associated proteases in lipid rafts. Cell Oncol (Dordr). 2016;39(4):353- 363. https://doi.org/10.1007/s13402-016-0280-x
Mushii O, Pavlova A, Bazas V, et al. Mast cells as a factor in regulation of breast cancer stromal component associated with breast cancer aggressiveness. Exp Oncol. 2025;46(4):311-323. https://doi.org/10.15407/exp-oncolo- gy.2024.04.311
Mushii O, Pavlova A, Bazas V, et al. Osteopontin-regulated changes in the mast cell population associated with breast cancer. Exp Oncol. 2024;46(3):209-220. https://doi.org/10.15407/exp-oncology.2024.03.209
Gu Y, Taifour T, Bui T, et al. Osteopontin is a therapeutic target that drives breast cancer recurrence. Nat Commun.
;15(1):9174. https://doi.org/10.1038/s41467-024-53023-9
Smirnova T, Bonapace L, MacDonald G, et al. Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor-associated macrophages. Oncotarget. 2016;7(50):82289-82304. https://doi. org/10.18632/oncotarget.12927
Garcia APV, Salvi M, Reis LA, et al. Tumor-associated macrophages and collagen remodeling in mammary carcinomas: a comparative analysis in dogs and humans. Int J Mol Sci. 2025;26(14):6928. https://doi.org/10.3390/ijms26146928
Brierley JD, Gospodarowicz MK, Wittekind C, et al. TNM Classification of Malignant Tumours. 8th ed. Wiley- Blackwell; 2017. ISBN: 978-1-119-26357-9.
Chekhun V, Mushii O, Zadvornyi T, et al. Features of COL1A1 expression in breast cancer tissue of young patients.
Exp Oncol. 2023;45(3):351-363. https://doi.org/10.15407/exp-oncology.2023.03.351
Zadvornyi T, Lukianova N, Borikun T, et al. Mast cells as a tumor microenvironment factor associated with the aggressiveness of prostate cancer. Neoplasma. 2022;69(6):1490-1498. https://doi.org/10.4149/neo_2022_221014N1020
Jeong SK, Kim JS, Lee CG, et al. Tumor-associated macrophages provide the survival resistance of tumor cells to hypoxic microenvironmental condition through IL-6 receptor-mediated signals. Immunobiology. 2017;222(1):55- 65. https://doi.org/10.1016/j.imbio.2015.11.010
Radharani NNV, Yadav AS, Nimma R, et al. Tumor-associated macrophage-derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via STAT-3 pathway. Cancer Cell Int. 2022;22(1):122. https:// doi.org/10.1186/s12935-022-02527-9
Xu Y, Zeng H, Jin K, et al. Immunosuppressive tumor-associated macrophages expressing interleukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer. J Immunother Cancer. 2022;10(3):e003416. https://doi.org/10.1136/jitc-2021-003416
Cha SM, Park JW, Lee YJ, et al. SPP1+ macrophages in HR+ breast cancer are associated with tumor-infiltrating lymphocytes. NPJ Breast Cancer. 2024;10(1):83. https://doi.org/10.1038/s41523-024-00695-7
Chen YC, Chen CC, Chen RF, et al. SPP1 mRNA expression is associated with M2 macrophage infiltration and poor prognosis in triple-negative breast cancer. Curr Issues Mol Biol. 2024;46(12):13499–13513. https://doi.org/10.3390/ cimb46120806
Gan L, Qiu Z, Huang J, et al. Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway. Int J Biol Sci. 2016;12(12):1533-1543. https://doi.org/10.7150/ijbs.15943
Lukianova N, Mushii O, Zadvornyi T, et al. Development of an algorithm for biomedical image analysis of the spatial organization of collagen in breast cancer tissue of patients with different clinical status. FEBS Open Bio. 2024;14(4):675-686. https://doi.org/10.1002/2211-5463.13773
Esbona K, Inman D, Saha S, et al. COX-2 modulates mammary tumor progression in response to collagen density.
Breast Cancer Res. 2016;18(1):35. https://doi.org/10.1186/s13058-016-0695-3
Maller O, Drain AP, Barrett AS, et al. Tumour-associated macrophages drive stromal cell-dependent collagen cross-linking and stiffening to promote breast cancer aggression. Nat Mater. 2021;20(4):548-559. https://doi.org/10.1038/ s41563-020-00849-5
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Experimental Oncology

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
